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Abstract
Background: Regional genomic copy number alterations (CNA) are observed in the vast majority of cancers. Besides
specifically targeting well-known, canonical oncogenes, CNAs may also play more subtle roles in terms of modulating
genetic potential and broad gene expression patterns of developing tumors. Any significant differences in the overall CNA
patterns between different cancer types may thus point towards specific biological mechanisms acting in those cancers. In
addition, differences among CNA profiles may prove valuable for cancer classifications beyond existing annotation systems.
Principal Findings: We have analyzed molecular-cytogenetic data from 25579 tumors samples, which were classified into
160 cancer types according to the International Classification of Disease (ICD) coding system. When correcting for
differences in the overall CNA frequencies between cancer types, related cancers were often found to cluster together
according to similarities in their CNA profiles. Based on a randomization approach, distance measures from the cluster
dendrograms were used to identify those specific genomic regions that contributed significantly to this signal. This
approach identified 43 non-neutral genomic regions whose propensity for the occurrence of copy number alterations
varied with the type of cancer at hand. Only a subset of these identified loci overlapped with previously implied, highly
recurrent (hot-spot) cytogenetic imbalance regions.
Conclusions: Thus, for many genomic regions, a simple null-hypothesis of independence between cancer type and relative
copy number alteration frequency can be rejected. Since a subset of these regions display relatively low overall CNA
frequencies, they may point towards second-tier genomic targets that are adaptively relevant but not necessarily essential
for cancer development.
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Introduction
Genetic changes such as point mutations, regional copy number
alterations/aberrations (CNA) and structural changes (e.g. gene
fusion events) are all hallmarks of cancer. CNAs arise as somatic
changes in the tumor cell genome through a variety of mechanisms
and can be observed in virtually all types of cancer, to a varying
extent. So far, the most widely used methods for the detection of
CNAs have been chromosomal and array-based Comparative
Genomic Hybridization (CGH) techniques [1–4]. Localized,
recurring CNAs (hot-spots) have been shown to target canonical
oncogenes (e.g. duplications/amplifications of the MYC, MYCN,
REL loci) or tumor suppressor genes (e.g. deletions of the
CDKN2A/B, TP53, ATM loci). Some regional CNAs such as
gains on 8q and losses on 3p are present across multiple cancer
types, whereas other imbalances may be largely restricted to a
limited number of cancer entities [5].
Datasets integrated across multiple cancer types have previously
been analyzed, to report regional ‘‘hot-spots’’ of frequent CNAs
[5,6]. In a given set of individual tumor samples, the number and
distribution of CNAs varies considerably [5] and this genetic
heterogeneity has been used to detect and report co-occurring
CNAs [7].
In principle, specific patterns and similarities in the individual
and/or disease specific CNA profiles might point to distinct
oncogenomic mechanisms acting in different cancer types and
specimens, given a sufficiently large number of data points.
Indeed, clustering of CNA patterns has been used to identify
oncogenomic similarities [5,8–11]. The adaptation of clustering
techniques to the analysis of CNA patterns has been subject of
previous studies [12–14]. With a few exceptions [5,14], however,
sample-based clustering has been the main focus of such studies so
far. In contrast, we here explore the clustering of cancer types, not
of individual cancer samples.
Both descriptive and clustering-based analyses of CNA across
multiple cancer types suffer from a bias towards the more
frequently occurring events. Due to the heterogeneity of the
overall CNA signal, with greatly varying average frequencies of
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CNAs per cancer type (Figure 1a), clustering results may be
distorted depending on the disease entities analyzed. This
variation in overall CNA occurrence frequencies across cancer
types may simply be owed to differences in the average time points
of clinical detection or in different progression characteristics, and
should be corrected for prior to clustering analyses. To the best of
our knowledge, so far no implementation has been reported for a
comprehensive, very large-scale clustering analysis of frequency-
normalized cancer CNA profiles.
Here, we focus on the identification of genomic regions that
contribute meaningfully to the clustering of cancer types. From
hereon we will refer to those as ‘‘non-neutral’’ regions. As the
starting point of our analysis, we use hierarchical clustering to
arrange cancer types on the basis of their CNA frequency profiles.
We then employ a permutation approach to estimate the relative
contribution of individual genomic regions to the quality of the
clustering and to the derived relationship tree. The clustering
quality is inferred from an intrinsic measure (summed branch
lengths: tree height statistics), and genomic regions that reject the
null hypothesis are termed non-neutral. Identified regions are
compared to canonical CNA hot-spots (i.e. those that occur most
frequently across the entire dataset).
Our current analysis is based on data from a total of 25579
samples, which are classified into 160 different cancer entities
(table S1) according to the International Classification of Disease
in Oncology (ICD-O 3). Our approach is unique in that it a)
focuses less on the clustering as such but more on the individual
genomic regions that best support the clustering, b) uses an
intrinsic quality measure coupled to a permutation strategy for
validation, c) performs CNA frequency normalization prior to
analysis, and d) is based on a very large data set, processed in a
standardized setup. We aim for the identification of potential
cancer-specific driver/modulator regions, which may not have
been detected in earlier, largely hot-spot-focused approaches. All
of the underlying cancer data is available through our Progenetix
repository (www.progenetix.org; [15]).
Results
The average overall frequency of CNAs across the entire
genome varies among different cancer types (Figure 1a). Since the
relative weight of CNAs at individual genomic regions in a given
cancer type depends on the observed overall genome-wide
frequency, we aggregated all patient samples by cancer type and
normalized the frequencies of CNAs for each cancer type to the
overall mean observed across the entire data set (Figure 1b, Figure
S1). The normalized CNA frequency profiles were then clustered
using hierarchical clustering.
To evaluate the quality and the biological signal in the
clustering, we labeled each cancer type with its ‘‘root’’ cell type
(i.e., an undifferentiated cell type from which the tumor likely
originated). We expected cancers of the same root cell type to
cluster together; this was used as an external proxy for the
expected biological relationships between cancer entities. The
Random Index [16] was used to compute this external cluster
quality measure. Tumors of the same cell type indeed often
clustered together, usually in 2–3 small groups (Figure 2). The
consistency of this grouping was significantly higher than expected
Figure 1. The overall frequency of genomic copy number alterations (CNA) differs among cancer types. Boxplots show the CNA
frequency distributions among tumor samples in 10 randomly selected cancer types. The boxplot delineations mark the percentiles 5%, 25%, 75%
and 95%. The red lines indicate the mean frequency for each cancer type, whereas the blue line represents the overall mean frequency across all 160
cancer types analyzed here. Frequency values are defined as the ratio of number of samples showing a CNA for a genomic region (i.e., cytogenetic
bands) over total number of samples in that cancer type. a) Before normalization b) After normalization. In b) the nominal frequency distribution for
each cancer type is re-scaled so that its mean matches the overall mean across all cancer types. (NOS – ‘‘not otherwise specified’’: high-order
classifications, not further assigned to more detailed levels).
doi:10.1371/journal.pone.0043689.g001
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at random, pointing towards biologically meaningful differences in
CNA profiles between tumors of distinct origins. Cutting the tree
at several heights always led to an observed quality of clustering
that was better than the expected random value (Figure 2), except
for the cut at the highest level, which resulted in only three
clusters. This strongly argues against a completely neutral
occurrence pattern of CNAs in the genome, and supports a
correlation between biologically meaningful groups of cancer
entities and their CNA profiles.
Randomizations of the entire frequency matrix lead to a
complete loss of the signal present in the clustering tree (Figure S2),
and also strongly reduced the summed branch lengths tree-height
statistic.
Non-neutral CNAs
The normalized and clustered frequency matrix encompassing
160 large-scale genomic regions and 160 cancer types is shown in
Figure 3. To determine how much each individual genomic region
contributes to the overall signal, we individually randomized its
profile across cancer types, while keeping the rest of the data
unchanged. We then examined the concomitant reduction in the
tree length statistics (TLS) of the clustering dendrogram, upon
100000 independent randomizations, to determine the statistical
significance of that region’s contribution. The resulting cancer-
diverging CNA regions are important as they cannot be fully
neutral and have the potential to define relationships among
cancer types. Indeed, 43 out of the 160 genomic regions (table S1)
were observed to have a non-neutral contribution (Bonferroni-
corrected p-value ƒ0:016) in the aggregated cancer CNA data.
Note that gain and loss events were treated independently, and no
preferential bias towards gains or losses was observed among the
detected non-neutral regions (22 gains and 21 losses). The CNA
occurrence frequencies of the non-neutral genomic regions spread
thorough the entire frequency spectrum (Figure 4). Only 13 (8
gains and 5 losses) of the non-neutral regions were found altered
overall more often than average (Figure 5, intersection of black
and grey rectangle), indicating that subset of frequently altered
hotspot regions carry a detectable signal to distinguish cancer types
(the number of frequently altered regions stands at 59; Bonferroni-
corrected p-valueƒ0:016, table S1). This observation emphasizes
our key point that not only the frequent CNA regions should be
used to cluster and annotate cancer types.
22 genomic intervals across 12 chromosomes were found to be
informative when specifically considering duplications/gains only
(Table 1 and Figure 5). All three genomic segments of
chromosome 18 (18p1, 18p2, 18q2) exhibited a signal. For other
chromosomes such as chromosome 1 (1q2,1q3,1q4,1p2), chromo-
some 3 (3q1, 3q2, 3p1), chromosome 12 (12q1,12q2) and
chromosome 21 (21p1, 21q1) more than 50% of genomic regions
were informative as gains, suggesting simultaneous involvement of
multiple loci from these chromosomes. Changes on chromosome
1(1p2), chromosome 3 (3p1, 3q1), chromosome 5 (5q2, 5q3),
chromosome 9 (9p1), chromosome 11 (11p1), chromosome 12
(12q1, 12q2), chromosome 18 (18p1, 18q1, 18q2) and chromo-
some 21 (21p1, 21q1) were selectively informative only as gains. In
terms of deletions/losses, 10 chromosomes encompassing 21
genomic regions were found to be non-neutral. Like for
chromosome 18 gains, the complete chromosome 7 (7p1, 7p2,
7q1, 7q2, 7q3) was found to be informative when lost (Table 1).
Informative regions on chromosome 1 (1p1,1q1, 1q2, 1q3, 1q4)
and chromosome 9 (9q1, 9q3, 9p2) covered more than 50% of
genomic segments present on these chromosomes. Selective losses
were observed on chromosome 1 (1p1, 1q1), chromosome 6 (6q2),
7 (7q1, 7q2, 7q3, 7p2), 8 (8q1, 8q2), 9 (9p2, 9q1, 9q3), 12 (12p1),
16 (16q1). CNAs involving chromosome 1 (1q2, 1q3, 1q4),
chromosome 3 (3q2), chromosome 7 (7p1), chromosome 19 (19p1)
and chromosome 22 (22q1) were informative both as gain and loss
events. This represents a small proportion (16%) of non-neutral
CNA. Involvement of a region both as gain and loss may point
towards multiple adaptively relevant loci, and/or towards a
generally unstable nature of these regions.
Cancer Diverging Nature of Non-neutral CNA
To provide few examples of cancer classifying behavior of non-
neutral changes, we selected a few of the enriched changes and
analyzed them for their specific occurrence in different cancers.
An example include cancer entities showing predominant losses
versus gains on 7q. Preferential losses involving 7q were observed
in germ cell, myeloid and myeloproliferative tumors (Figure 3)
whereas neuroepithelial brain tumors (among other entities)
preferentially displayed gains on 7q. Losses involving 7q are
common in myeloid and myeloproliferative tumors [17–20] and
are associated with advanced age and resistance to therapies
[21,22]. However, here we show that 7q losses are quite specific to
myeloid tumors and promote their selective divergence from other
cancer types. 7q losses in germ cell tumors had not been explored
in detail [23,24]. With the accumulation of 7q losses virtually
restricted to myeloid/myeloproliferative neoplasias and germ cell
tumors and in contrast to chromosome 7(q) gains observed in e.g.
neuroepithelial brain tumors, it is tempting to propose involve-
ment of at least one common oncogenetic mechanism acting in
these clinically unrelated malignancies.
Chromosome 8q gains can be observed in the majority of
cancer entities [5,6]. However, in our analysis 8q losses were
enriched as non-neutral events. Preferential losses involving 8q
were present in some brain tumors (e.g. medulloblastoma,
Figure 3), separating them from other epithelial tumors. Differ-
ences in preferential losses involving 8q separated neuroepithelial
tumors in two categories with both having gains on 7q but only
one (mainly meduloblastomas) having preferential losses on 8q
(Figure S3). Losses involving chromosome 8q across medulloblas-
tomas have been reported by a few [25] studies before. Our
analysis shows that 8q losses are selected for in some medullo-
blastomas and therefore could be important for cancer develop-
ment/progression. Preferential losses of 8q were also observed in
germ cell tumors separating them from other epithelial neoplasias
(Figure S4).
As another example of restricted CNA types we also looked for
cancers showing gains involving chromosome 18. Follicular
lymphomas exhibited specific gains on chromosome 18 where as
epithelial tumors prefered to loose chromosome 18 (Figure S4).
Chromosome 18 gains are very common in follicular lymphomas
and are supposed to provide an alternative mechanism for BCL2
activation [26,27]. However, here we show that this CNA event
statistically separates them from other cancer types.
Discussion
Our current study represents the largest analysis performed to
date on cancer CNA data, with the aim of detecting oncogenomic
features that may be specifically associated or enriched in certain
subsets of cancer entities. In contrast to gene-centric approaches,
our analysis assesses the complete information space of genomic
copy number imbalances from whole genome profiling experi-
ments.
Overall, the frequency of CNAs across genomic intervals varied
between between 0.01% to 23% (Figure 4). Clustering of cancer
types on the basis of their frequency profiles helped to identify a
Regional Genomic Copy Number Alterations in Cancer
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Figure 2. The tissue type of a cancer has a strong influence on its CNA likelihood pattern. a) examples of individual chromosome
segments, showing their observed CNA frequencies stratified by cell type. Each dot summarizes all samples classified under one particular ICD type,
color-coded by root cell type. In the left panel, three chromosome segments are shown that exhibit strong differences between cell types; on the
right, three negative examples without such a signal. All p-values were corrected for multiple testing according to Benjamini-Hochberg. b) the
Regional Genomic Copy Number Alterations in Cancer
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class of underlying molecular signals that is orthogonal to
histological classifications or clinical categories (the latter are
predominantly driven by the affected organ/tissue). Cancer types
vary from each other in their CNA abundance, CNA size
spectrum and degree of genomic instability. With respect to
genomic coverage, large CNAs are generally frequent in cancer
[6] and should not be excluded from statistical analyses of cancer
genome patterns. While comparing CNA profiles of cancer types,
their complexity and variation in frequencies have to be
considered. When correcting for these parameters, regional CNAs
defining the divergence of the overall profiles can be delineated.
We performed an analysis of a global cancer CNA dataset,
identifying 43 genomic regions on 15 chromosomes as significant
for CNA profile divergence in cancer types. Obviously, these
changes do not cover the entire spectrum of CNA events in cancer,
but define a subset of genomic regions that may have a possibly
adaptive link to the distinct biology of various cancer types. These
regions overlap rather poorly with hot-spot regions observed in
many cancers. This suggests that hot-spot regions, though
frequently associated with canonical oncogenes, may not always
be very useful in aiding data-driven evaluation of cancer (sub-)
types.
Disease specific studies have the potential to detect a
representative spectrum of oncogenomic aberrations in the given
entities. It can be expected that the cancer type specific regions
highlighted with our approach had been discussed in the context
of the respective publications. However, with our current study,
we aim to provide a new, generalized approach at identifying
genomic elements relevant in the genesis of individual cancer
entities. Although here showcasing a ‘‘global’’ approach without
entity pre-selection, our methodology may prove valuable when
targeting relevant genomic separators in limited, biologically
related entity sets.
Since the current analysis is based primarily on molecular-
cytogenetic data from chromosomal CGH experiments with a
spatial resolution of several megabases, only inferred information
about the causal genes present in the non-neutral regions could be
obtained. With upcoming high-resolution genomic array and/or
sequencing data, similar analyses will more specifically define the
non-neutral CNAs and can be valuable starting points for an
integration of the results with functional pathway frameworks. We
have recently announced the creation and public availability of a
reference resource for oncogenomic array data (www.arraymap.
org [28]), which will serve as starting point for such approaches
dendrogram (tree) has been obtained using hierarchical Ward clustering on the global frequency-normalized CNA profiles across all 160 genomic
regions. Cancer types are again color-coded according to the cell type of origin, with the same legend as in a). Partitioning the tree by cutting at
different heights produces multiple clusters; validation of those clusters based on the cancer origin (metric: Random Index) shows that the clustering
works significantly better than expected at random.
doi:10.1371/journal.pone.0043689.g002
Figure 3. Examples for non-neutral CNA regions. a) Heatmap of CNA profiles on genomic regions (same clustering as in Figure 2). Genomic
locations are represented with orange color when considering duplications/gains, and in blue when considering deletions/losses. Color intensity
shows relative CNA frequencies; the most-affected region in each row is arbitrarily set the to brightest color (1.0) for display purposes. b) Small
regions (black rectangles on the heatmap) are zoomed in to show how non-neutral CNAs can differentiate between cancer types. The example shows
that 7q is preferentially gained in brain tumors (red labels) whereas it is preferentially lost in germ cell (black labels), myeloid and myeloproliferative
cancer types (blue labels). c) Small regions (red rectangles on the heatmap) are zoomed in to show how 8q is preferentially lost in medullublastomas
(green labels) and is preferentially gained in epithelial tumors (pink labels). Some chromosomes consist entirely of non-neutral regions (such as
chromosomes 18 and 7). Note that the spatial resolution of the CNA data on the chromosome is limited (roughly corresponding to cytogenetic band
resolution).
doi:10.1371/journal.pone.0043689.g003
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both from our side as well as from interested members of the
research community. Also, although we have focused our current
analysis solely on a CNA dataset, our methodology should prove
particularly valuable when combined with other sets of related
diagnostics (for example point mutation data), whereby the
assignment of possible driver genes in the non-neutral regions
might become feasible.
Figure 4. Not only CNA ‘‘hotspots’’ are informative in cancer classification. Genomic regions (bands) are sorted according to their overall
frequency of CNAs observed. Those regions that are informative with respect to cancer type clustering are marked with arrows. a) Considering
duplications (gains) b) Considering deletions (losses).
doi:10.1371/journal.pone.0043689.g004
Figure 5. Comparison of non-neutral vs. hot-spot CNA. Genomic regions affected by CNAs, either more frequently than average (black
rectangle), or non-neutrally with respect to cancer-type classifications (grey rectangle). The intersection defines regions that are affected both
frequently and non-neutrally. Changes are color-coded (gains in orange and losses in blue).
doi:10.1371/journal.pone.0043689.g005
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Materials and Methods
Data
Our study is based on well annotated cancer CNA data from
the Progenetix project [5], including a total of 25579 samples
analyzed by chromosomal (cCGH; 18708) and array CGH
(aCGH; 6871) experiments. The clinical samples had been
classified into 160 distinct cancer entities according to the
International Classification of Disease codes (ICD). At the time
of writing, the Progenetix collection represents the largest resource
for annotated, whole genome CNA profiling data in cancer.
For our analysis, regional CNA information across all cancer
types was reduced to 80 genomic intervals covering the entire
genome with the exception of the sex chromosomes. Gain and loss
events were considered separately for the analysis, resulting in a
matrix of dimensions nXm, where n is the number of samples and
m is the number of genomic intervals (i.e. 160).
Cancer Clustering
The frequency of CNA changes across all genomic intervals was
computed for each ICD type, and the entire frequency matrix was
then normalized (Figure S1). The frequency matrix was ordered
using hierarchical Ward clustering. The aggregated separation
distance between cancer entities obtained using hierarchical
clustering can be analyzed by parsing the clustering tree
(dendrogram). The tree represents the relatedness among groups
present in the same clade (similar to phylogenetic trees).
Randomized data disrupts the tree completely (Figure S2), and
the overall tree height statistic is reduced 3-fold, reflecting the
complete loss of ordering information present in the original tree.
Method to Compare Tree Height
We used the tree height as an intrinsic measure to compare
cancer associations obtained using clustering and to gauge the
information present in the tree; this was used to define non-neutral
CNAs. This has advantages over traditional clustering evaluation
techniques, as it a) does not require external gold standard
information, and b) does not require cutting the tree at an
arbitrary distance. The overall tree height is defined as the sum of
all direct parent-child relation path lengths in the tree. Tree
distances (branch lengths) generally reflect the CNA profile
discrepancies between two cancers (or groups of cancers). For
any node i, the tree height between this node and its immediate
parent j can be measured as THj{THi. The overall tree height of
a tree with n nodes is than obtained as OTH =Pi~n,j~n
i~1,j~1 THj{THi (figure S3).
Tree length statistics (TLS). To identify genomic regions
that are non-neutrally affected by CNA we have developed the
following permutation strategy:
1. Normalized frequencies of CNA across all genomic intervals
are computed across all cancer types.
2. The cancer classification tree is obtained using hierarchical
Ward clustering.
3. The observed over all tree height (OTHo) is calculated as
mentioned above (Figure S5).
Table 1. Number of non-neutral regions per chromosome.
Chromosome No. No. genomic locations Non-neutral gains Non-neutral losses
1 7 4 5
2 5 – –
3 4 3 1
4 4 – –
5 4 2 –
6 4 – 1
7 5 1 5
8 4 – 2
9 5 1 3
10 3 – –
11 3 1 –
12 3 2 1
13 4 1 –
14 4 – –
15 3 – –
16 3 – 1
17 3 – –
18 3 3 –
19 2 1 –
20 2 – –
21 3 2 –
22 2 1 –
Some chromosomes consist entirely of non-neutral regions (such as choromosomes 18 and 7). Note that the spatial resolution of the CNA data on the chromosome is
limited (it roughly corresponds to the cytogenetic banding patterns).
doi:10.1371/journal.pone.0043689.t001
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4. A counter C is set to zero for every genomic interval in
consideration.
5. For any genomic interval i, its status values are shuffled among
all samples keeping its over all frequency the same (ni).
6. The frequency of CNA at genomic interval i is re-calculated
after randomization across all cancer types. The shuffling in the
previous step changes the frequency of interval i across all
cancer types keeping the normalized frequency distribution of
all other genomic intervals.
7. The frequencies for interval i in the normalized frequency
matrix from step one are replaced with permuted frequencies
for this interval and the permuted overall tree heigh (OTHi,p) is
computed.
8. If OTHi,p§OTHo, C is incremented as C=C+1.
9. p-value for genomic location i, at the end of N (100’000)
permutations is computed as pi~C=N.
10. p-values across all bands are corrected for false discovery
rate using Bonferroni correction.
Frequency Based Enrichment (FBE)
Frequently observed CNA regions (‘‘hot-spots’’) are genomic
changes that occur more often than expected under a fully random
null model. Such hot-spot CNAs can be identified using the
binomial probability function [29]. Let’s suppose genomic interval
i shows a CNA across ni samples out of N samples. The
background CNA frequency (nb) can be represented as the mean
frequency change across all intervals. The p value that the
frequency of CNA ni, is more than any frequency x (ni§x) is
obtained using the binomial probability function.
p(ni DN,nb)~
N
ni
 
n
ni
b (1{nb)
N{ni
pi~
XN
n~x
p(ni DN,nb)
Genomic intervals showing a large deviation from the mean will
be assigned low p-values. All p-values are corrected for false
discovery rate using Bonferroni correction.
Supporting Information
Figure S1 Method for CNA frequency normalization
across cancer types. All the frequencies among cancer types
were normalized to the mean frequency of CAN changes across
across the 160 cancer types. This normalization was achieved by
multiplying the cancer-type-specific frequencies with an index An,
whose value was calculated as shown.
(PNG)
Figure S2 Dendrogram of a permuted frequency ma-
trix. For this clustering, the frequencies among cancer types were
permuted and then normalized. Hierarchial Ward clustering was
then performed and the dendrogram tree shown was obtained.
The tree height is severely affected by the permutation. In this
randomized clustering, similar cancer types no longer clustered
together.
(PDF)
Figure S3 Small regions from heatmap in main Figure 3
are shown here. These regions represent gains and losses on 7q
and 8q. 8q changes differentiate between two categories of brain
tumors, with a subset showing preferential losses on 8q (green
labels) and other rarely showing involvement of 8q locus (red
label). Thus depending on 8q involvement neuroepithelial tumors
can be divided in to two different categories. Both of them show 7q
gains.
(PDF)
Figure S4 Examples for non-neutral CNA regions. a)
Heatmap of CNA profiles on genomic regions (same as in
Figure 3). b) Small regions (red rectangles on the heatmap) are
zoomed in to show how 8q is preferentially lost in in germ cell
(black labels) tumors and is preferentially gained in epithelial
cancer types (pink labels). c) Small regions (black rectangles on the
heatmap) are zoomed in to show how 18q is preferentially gained
in medullublastomas (brown labels) and is preferentially lost in
epithelial tumors (pink labels). The examples here show that how
two different non-neutral changes differential epithelial tumors
from germ cell tumors and follicular lymphomas.
(PDF)
Figure S5 Calculation of over all tree height. Schematic
representation of the summed branch-length tree height statistic.
Overall tree height is computed by summing up the distance
between all parents and child nodes. Note that the branch lengths
of terminal branches (‘‘leafs’’) are not considered. Overall tree
height = HA{CzHBDzHABzHE .
(PDF)
Table S1 Table with information about cancer types
used in the analysis, non-neutral and hot-spot p values.
The table giving details about all cancer types used in this analysis
with the corresponding numbers of samples in them and the root
cell type of each cancer. The table also has information about the
non-neutral and hot-spot p-values obtained for all genomic bands
in analysis.
(ODS)
Author Contributions
Conceived and designed the experiments: NK HC CvM MB. Performed
the experiments: NK HC MB. Analyzed the data: NK HC CvM MB.
Contributed reagents/materials/analysis tools: NK HC MB. Wrote the
paper: NK CvM MB.
References
1. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, et al. (1992)
Comparative genomic hybridization for molecular cytogenetic analysis of solid
tumors. Science 258: 818–21.
2. Joos S, Scherthan H, Speicher MR, Schlegel J, Cremer T, et al. (1993) Detection
of amplified dna sequences by reverse chromosome painting using genomic
tumor dna as probe. Hum Genet 90: 584–9.
3. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, et al. (1997)
Matrix-based comparative genomic hybridization: biochips to screen for
genomic imbalances. Genes Chromosomes Cancer 20: 399–407.
4. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution
analysis of dna copy number variation using comparative genomic hybridization
to microarrays. Nat Genet 20: 207–11.
5. Baudis M (2007) Genomic imbalances in 5918 malignant epithelial tumors: an
explorative metaanalysis of chromosomal cgh data. BMC Cancer 7: 226.
6. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, et al. (2010) The
landscape of somatic copy-number alteration across human cancers. Nature 463:
899–905.
7. Kumar N, Rehrauer H, Cai H, Baudis M (2011) Cdcoca: a statistical method to
define complexity dependence of co-occuring chromosomal aberrations. BMC
Med Genomics 4: 21.
Regional Genomic Copy Number Alterations in Cancer
PLOS ONE | www.plosone.org 8 August 2012 | Volume 7 | Issue 8 | e43689
8. Myllykangas S, Himberg J, Bo¨hling T, Nagy B, Hollme´n J, et al. (2006) Dna
copy number amplification profiling of human neoplasms. Oncogene 25: 7324–
7332.
9. Liu J, Ranka S, Kahveci T (2007) Markers improve clustering of cgh data.
Bioinformatics 23: 450–7.
10. Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, et al. (2008)
Comparative genome profiling across subtypes of low-grade b-cell lymphoma
identifies type-specific and common aberrations that target genes with a role in
b-cell neoplasia. Haematologica 93: 670–679.
11. Takeuchi I, Tagawa H, Tsujikawa A, Nakagawa M, Katayama-Suguro M, et al.
(2009) The potential of copy number gains and losses, detected by array-based
comparative genomic hybridization, for computational differential diagnosis of
b-cell lymphomas and genetic regions involved in lymphomagenesis. Haema-
tologica 94: 61–69.
12. Liu J, Ranka S, Kahveci T (2006) Markers improve clustering of cgh data.
Bioinformatics 23: 450–457.
13. Wieringen WNV, Wiel MAVD, Ylstra B (2008) Weighted clustering of called
array cgh data. Biostatistics 9: 484–500.
14. Liu J, Bandyopadhyay N, Ranka S, Baudis M, Kahveci T (2009) Inferring
progression models for cgh data. Bioinformatics 25: 2208–15.
15. Baudis M, Cleary ML (2001) Progenetix.net: an online repository for molecular
cytogenetic aberration data. Bioinformatics 17: 1228–9.
16. Tan PN, Steinbach M, Kumar V (2005) Introduction to data mining. Bosotn,
MA, USA: Addison Wesley.
17. Ku¨hn MWM, Radtke I, Bullinger L, Goorha S, Cheng J, et al. (2012) High-
resolution genomic profiling of adult and pediatric core-binding-factor acute
myeloid leukemia reveals new recurrent genomic alterations. Blood.
18. Woo KS, Kim KE, Kim KH, Kim SH, Park JI, et al. (2009) Deletions of
chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker
chromosome confirmed by array comparative genomic hybridization. Cancer
Genet Cytogenet 194: 71–4.
19. Cordoba I, Gonza´lez-Porras JR, Nomdedeu B, Lun˜o E, de Paz R, et al. (2012)
Better prognosis for patients with del(7q) than for patients with monosomy 7 in
myelodysplastic syndrome. Cancer 118: 127–133.
20. Aktas D, Tuncbilek E (2006) Myelodysplastic syndrome associated with
monosomy 7 in childhood: a retrospective study. Cancer Genet Cytogenet
171: 72–5.
21. Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, et al. (2006)
Age and acute myeloid leukemia. Blood 107: 3481–5.
22. Wong JCY, Zhang Y, Lieuw KH, Tran MT, Forgo E, et al. (2010) Use of
chromosome engineering to model a segmental deletion of chromosome band
7q22 found in myeloid malignancies. Blood 115: 4524–32.
23. McIntyre A, Summersgill B, Lu YJ, Missiaglia E, Kitazawa S, et al. (2007)
Genomic copy number and expression patterns in testicular germ cell tumours.
Br J Cancer 97: 1707–12.
24. Veltman I, Veltman J, Janssen I, van de Kaa CH, Oosterhuis W, et al. (2005)
Identification of recurrent chromosomal aberrations in germ cell tumors of
neonates and infants using genomewide array-based comparative genomic
hybridization. Genes Chromosomes Cancer 43: 367–76.
25. jing Sun Y, zhu Yu S, yun Sun C, Wang Q, mei Jin S, et al. (2010) [detection of
chromosomal dna imbalance in medulloblastoma by comparative genomic
hybridization]. Zhonghua Bing Li Xue Za Zhi 39: 606–10.
26. Cheung KJJ, Delaney A, Ben-Neriah S, Schein J, Lee T, et al. (2010) High
resolution analysis of follicular lymphoma genomes reveals somatic recurrent
sites of copy-neutral loss of heterozygosity and copy number alterations that
target single genes. Genes Chromosomes Cancer 49: 669–81.
27. Schwaenen C, Viardot A, Berger H, Barth TFE, Bentink S, et al. (2009)
Microarray-based genomic profiling reveals novel genomic aberrations in
follicular lymphoma which associate with patient survival and gene expression
status. Genes Chromosomes Cancer 48: 39–54.
28. Cai H, Kumar N, Baudis M (2012) arraymap: A reference resource for genomic
copy number imbalances in human malignancies. PLoS One 7: 36944.
29. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse
somatic mutation patterns and pathway alterations in human cancers. Nature
466: 869–873.
Regional Genomic Copy Number Alterations in Cancer
PLOS ONE | www.plosone.org 9 August 2012 | Volume 7 | Issue 8 | e43689
